⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18845026 | 0.82 | — | — | |
| SCHEMBL979693 | 0.79 | — | — | |
| SCHEMBL420617 | 0.76 | — | — | |
| SCHEMBL7338073 | 0.76 | — | — | |
| SCHEMBL419742 | 0.76 | — | — | |
| SCHEMBL9422903 | 0.76 | HIF1A (0.43) | — | |
| SCHEMBL7303716 | 0.76 | HIF1A (0.43) | — | |
| SCHEMBL18196023 | 0.72 | ALDH1A1 (0.39) | — | |
| SCHEMBL9423576 | 0.71 | — | — | |
| SCHEMBL981029 | 0.70 | CALM1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230002436-A1 | MODIFIED NUCLEOTIDES AND USES THEREOF | FIRST-CITIZENS BANK & TRUST COMPANY | 2023-01-05 | — | — | US | disclosed |
| US-11174281-B1 | Modified nucleotides and uses thereof | Singular Genomics Systems, Inc. (US) | 2021-11-16 | — | — | US | disclosed |
| WO-2017011418-A1 | ORGANIC REACTION UTILIZING AN α,β-UNSATURATED COMPOUND | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2017-01-19 | — | — | WO | disclosed |
| US-9364554-B2 | Extracellular targeted drug conjugates | CENTROSE LLC (US) | 2016-06-14 | — | — | US | disclosed |
| US-8703723-B2 | Glycoside compounds and pharmaceutical compositions thereof | CENTROSE, LLC (US) | 2014-04-22 | — | — | US | disclosed |
| US-8470980-B2 | Extracellular targeted drug conjugates | CENTROSE, LLC (US) | 2013-06-25 | — | — | US | disclosed |
| US-8361973-B2 | Glycoside compounds and pharmaceutical compositions thereof | CENTROSE, LLC (US) | 2013-01-29 | — | — | US | disclosed |
| WO-2012139891-A1 | SUBSTITUTED VINYL AND ALKINYL CYCLOHEXENOLS AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS | BAYER CROPSCIENCE AG (DE) | 2012-10-18 | — | — | WO | disclosed |
| US-20110319350-A1 | GLYCOSIDE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | CENTROSE, LLC (US) | 2011-12-29 | — | — | US | disclosed |
| US-20110064752-A1 | EXTRACELLULAR TARGETED DRUG CONJUGATES | CENTROSE, LLC (US) | 2011-03-17 | — | — | US | disclosed |
| US-20110014504-A1 | LITHIUM SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2011-01-20 | — | — | US | disclosed |
| US-7619101-B2 | Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2H-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one | HOFFMAN-LA ROCHE INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-20080311478-A1 | Lithium Secondary Battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
| EP-1892789-A1 | LITHIUM SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2008-02-27 | — | — | EP | disclosed |
| US-20060270853-A1 | Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one | HOFFMANN-LA ROCHE INC. | 2006-11-30 | — | — | US | disclosed |
| EP-0293748-B1 | PROCESS FOR THE PREPARATION OF 2(5H)-FURANONES | BASF Aktiengesellschaft (DE) | 1992-01-29 | — | — | EP | disclosed |
| US-4853473-A | Preparation of 2(5H)-furanones | BASF AKTIENGESELLSCHAFT (DE) | 1989-08-01 | — | — | US | disclosed |
| EP-0293748-A2 | Process for the preparation of 2(5H)-furanones | BASF Aktiengesellschaft (DE) | 1988-12-07 | — | — | EP | disclosed |